AFLD 2012 FFC vs Respondent M44

Facts
The French Cycling Federation (Fédération Française de Cyclisme, FFC) charges respondent M44 for a violation of the Anti-Doping Rules. During a cycling match on August 10, 2011, a sample was taken for doping control purposes. The analysis of the sample showed the presence of Erythropoietin. Erythropoietin is a prohibited substance according the World Anti-Doping Agency (WADA) prohibited list.

History
The respondent denies the use of erythropoietin and doubts the doping control proceedings.

Decision
1. The sanction is a period of ineligibility of 2 years in which the correspondent can't take part in competition or manifestations organized or authorized by the French sport federations.
2. The period of ineligibility will be reduced by the period already served in voluntary suspension.
3. The decision dated September 23, 2011, from the disciplinary committee of the FFC will be modified.
4. The decision will be published and sent to the parties involved.

Original document

Parameters

Legal Source
National Decisions
Date
26 April 2012
Original Source
French Anti-Doping Agency (AFLD)
Country
France
Language
French
ADRV
Adverse Analytical Finding / presence
Sport/IFs
Cycling (UCI) - International Cycling Union
Other organisations
Fédération Française de Cyclisme (FFC) - French Cycling Federation
Doping classes
S2. Peptide Hormones, Growth Factors
Substances
Erythropoietin (EPO)
Document type
Pdf file
Date generated
14 February 2014
Date of last modification
6 June 2014
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin